Intellipharmaceutics’ Oxycodone ER Returns To US FDA Panel Looking For Abuse-Deterrence Claim

 
• By Sue Sutter
Addict man make injection of drugs
Aximris XR can be expected to have some deterrent effect by the intravenous route of abuse, the FDA says. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers